Citigroup
AMPE

Citigroup’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Citigroup’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed – – 6207
2022
Q3 		$0 Sell
2
-135
-99% -$4.73K ﹤0.01% 6624
2022
Q2 		$7K Buy
137
+91
+198% +$6.77K ﹤0.01% 5527
2022
Q1 		$6K Sell
46
-124
-73% -$18.1K ﹤0.01% 5789
2021
Q4 		$29K Buy
170
+90
+113% +$33.6K ﹤0.01% 5288
2021
Q3 		$40K Buy
80
+48
+150% +$22.3K ﹤0.01% 4872
2021
Q2 		$16K Buy
32
+30
+1,500% +$16.1K ﹤0.01% 5447
2021
Q1 		$1K Sell
2
-20
-91% -$10.3K ﹤0.01% 6138
2020
Q4 		$10K Sell
22
-16
-42% -$5.25K ﹤0.01% 6966
2020
Q3 		$11K Hold
38
– – ﹤0.01% 6583
2020
Q2 		$7K Hold
38
– – ﹤0.01% 7199
2020
Q1 		$5K Sell
38
-38
-50% -$6.88K ﹤0.01% 7285
2019
Q4 		$13K Hold
76
– – ﹤0.01% 7122
2019
Q3 		$12K Sell
76
-47
-38% -$6.26K ﹤0.01% 7006
2019
Q2 		$14K Sell
123
-43
-26% -$6.81K ﹤0.01% 7213
2019
Q1 		$28K Buy
166
+40
+32% +$6.85K ﹤0.01% 6778
2018
Q4 		$15K Sell
126
-64
-34% -$9.82K ﹤0.01% 7020
2018
Q3 		$29K Buy
190
+91
+92% +$38K ﹤0.01% 6906
2018
Q2 		$65K Buy
+99
New +$74.1K ﹤0.01% 6089
2018
Q1 		– Hold
0
– – – 7729
2017
Q2 		– Sell
-12
Closed -$3K – 7548
2017
Q1 		$3K Sell
12
-160
-93% -$43K ﹤0.01% 6961
2016
Q4 		$47K Buy
172
+149
+648% +$35.5K ﹤0.01% 6181
2016
Q3 		$5K Sell
23
-5
-18% -$1.4K ﹤0.01% 6792
2016
Q2 		$11K Buy
28
+15
+115% +$16.4K ﹤0.01% 6515
2016
Q1 		$9K Sell
13
-2
-13% -$1.35K ﹤0.01% 6843
2015
Q4 		$15K Sell
15
-5
-25% -$4.95K ﹤0.01% 6636
2015
Q3 		$17K Buy
20
+5
+33% +$4.18K ﹤0.01% 6155
2015
Q2 		$11K Sell
15
-27
-64% -$28.8K ﹤0.01% 6432
2015
Q1 		$96K Buy
42
+13
+45% +$22.2K ﹤0.01% 5058
2014
Q4 		$30K Buy
29
+18
+164% +$19.2K ﹤0.01% 6009
2014
Q3 		$12K Hold
11
– – ﹤0.01% 6187
2014
Q2 		$26K Sell
11
-15
-58% -$30.6K ﹤0.01% 5662
2014
Q1 		$50K Sell
26
-30
-54% -$70.9K ﹤0.01% 5490
2013
Q4 		$119K Buy
+56
New +$132K ﹤0.01% 5117
2013
Q3 		– Hold
0
– – – 6712
2013
Q2 		– Hold
0
– – – 6816

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Citigroup's AMPE Position: Q4 2022 in Review

Citigroup sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 2 shares.

Citigroup first reported a position in AMPE in Q4 2013 and held it in 32 quarters. The position peaked at $119K in Q4 2013. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Citigroup reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 2 Ampio Pharmaceuticals Inc. shares in Q4 2022.
  • Citigroup first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and held it in 32 quarters.
  • Citigroup's Ampio Pharmaceuticals Inc. position peaked at $119K in Q4 2013.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.